We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+2.53%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$1.95B
AUM Growth
-$46.9M
Cap. Flow
-$62.6M
Cap. Flow %
-3.21%
Top 10 Hldgs %
49.13%
Holding
66
New
15
Increased
17
Reduced
12
Closed
17

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$61.3M
2
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$59.5M
3
UHS icon
Universal Health Services
UHS
+$53.1M
4
AGN
Allergan Inc
AGN
+$41.6M
5
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$39.1M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$78.3M
2
CFN
CAREFUSION CORPORATION
CFN
+$71M
3
EHTH icon
eHealth
EHTH
+$61.7M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$53.4M
5
MDVN
MEDIVATION, INC.
MDVN
+$46.7M

Sector Composition

Rank Sector Weight
1 Healthcare 64.19%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRI
26
DELISTED
Albany Molecular Research Inc
AMRI
$30.9M 1.59%
1,400,000
+525,000
+60% +$10.8M
A icon
27
CALL
Agilent Technologies
A
$39.1B
$28.5M 1.46%
+699,000
New +$28.5M
ALXN
28
DELISTED
Alexion Pharmaceuticals
ALXN
$24.9M 1.28%
150,000
-325,000
-68% -$53.4M
OCR
29
DELISTED
OMNICARE INC
OCR
$21.8M 1.12%
+350,000
New +$22.2M
AKBA icon
30
Akebia Therapeutics
AKBA
$354M
$19.9M 1.02%
900,000
– –
INFI
31
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$15.6M 0.8%
1,162,200
+238,600
+26% +$2.84M
AEGR
32
DELISTED
Aegerion Pharmaceuticals
AEGR
$15.5M 0.79%
+463,700
New +$14.4M
BKD icon
33
Brookdale Senior Living
BKD
$3.49B
$15.1M 0.78%
470,000
+145,000
+45% +$4.94M
ARAV
34
DELISTED
Aravive, Inc. Common Stock
ARAV
$14.2M 0.73%
125,000
+16,667
+15% +$2.21M
ARIA
35
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$12.8M 0.66%
2,365,000
+1,015,000
+75% +$5.93M
RGLS
36
DELISTED
Regulus Therapeutics
RGLS
$10.6M 0.54%
12,917
– –
NPSP
37
CALL
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$10.4M 0.53%
+400,000
New +$11.5M
DSCI
38
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$7.66M 0.39%
920,000
– –
TMO icon
39
Thermo Fisher Scientific
TMO
$213B
$6.73M 0.35%
+55,300
New +$6.72M
ACHN
40
CALL
DELISTED
Achillion Pharmaceuticals
ACHN
$4.99M 0.26%
+500,000
New +$4.64M
XOMA
41
CALL
DELISTED
Xoma
XOMA
$4.21M 0.22%
+50,000
New +$4.27M
CSII
42
DELISTED
Cardiovascular Systems, Inc.
CSII
$3.97M 0.2%
167,900
+63,500
+61% +$1.81M
VIRX
43
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$3.8M 0.2%
2,536
-750
-23% -$1.09M
NVAX icon
44
Novavax
NVAX
$1.2B
$2.46M 0.13%
29,500
+9,500
+48% +$859K
ELOS
45
DELISTED
Syneron Medical Ltd
ELOS
$2.29M 0.12%
228,800
– –
ACGN
46
DELISTED
Aceragen Inc
ACGN
$1.95M 0.1%
+6,256
New +$2.25M
AERI
47
DELISTED
Aerie Pharmaceuticals
AERI
$1.55M 0.08%
+75,000
New +$1.48M
XOMA
48
DELISTED
Xoma
XOMA
$640K 0.03%
+7,600
New +$648K
ACAD icon
49
Acadia Pharmaceuticals
ACAD
$4.43B
– –
-216,500
Closed -$4.89M
COR icon
50
PUT
Cencora
COR
$60.6B
– –
-145,000
Closed -$10.5M
1
2
3

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q3 2014 Portfolio in Review

As of Q3 2014, HealthCor Management held 66 positions worth $1.95B, down 2.3% from $1.99B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

HealthCor Management withdrew a net $62.6M in Q3 2014, closing 17 positions and reducing 12 holdings. Its most notable exit was CAREFUSION CORPORATION, an estimated $71M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, down from 73% a quarter earlier, followed by Financials.

Against the trend, HealthCor Management opened a new position in Universal Health Services worth $52.3M.

  • HealthCor Management's largest Q3 2014 buy was Universal Health Services: 500,000 shares worth $52.3M.
  • HealthCor Management added most to Biogen in Q3 2014, an estimated $61.3M increase.
  • HealthCor Management's biggest Q3 2014 reduction was Allergan plc, cutting an estimated $78.3M.
  • HealthCor Management fully exited CAREFUSION CORPORATION in Q3 2014, selling an estimated $71M.
  • HealthCor Management's ten largest holdings make up 49% of its $1.95B portfolio in Q3 2014.
  • HealthCor Management opened 15 new positions and closed 17 in Q3 2014.
  • HealthCor Management's portfolio value fell 2.3% quarter-over-quarter to $1.95B.

Based on HealthCor Management's 13F filing for Q3 2014, filed 14 Nov 2014.